A secondary endpoint is an additional outcome measure in a clinical trial that is not the primary focus of the study. These endpoints are used to evaluate other effects of the intervention or treatment being tested, providing supplementary information to support or complement the primary endpoint results.
Secondary endpoints are typically specified in the study protocol and analyzed after the primary endpoint. While they may offer valuable insights, secondary endpoints generally carry less statistical power and are considered supportive rather than definitive evidence of a treatment’s efficacy or safety.
Secondary endpoints play a crucial role in providing a more comprehensive understanding of a treatment’s effects beyond the primary outcome. They allow researchers to explore additional aspects of efficacy, safety, or quality of life that may be relevant to patients, healthcare providers, or regulatory agencies.
The inclusion of secondary endpoints enhances the overall value of a clinical trial by maximizing the information gathered from study participants. This broader assessment can help identify unexpected benefits or risks, guide future research directions, and inform clinical decision-making, even if the primary endpoint does not meet its objectives.
The Axcellant team recently attended the International Conference on Nuclear Cardiology (ICNC) in Berlin – one of the most important…
Axcellant is pleased to announce the formation of its Advisory Board - a group of distinguished experts in clinical science,…
The FDA and the European Commission are changing the rules of the game simultaneously. The shift is from a single…
Copyright @ 2026 Axcellant